Cargando…

Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil

Zika virus infection is associated with the development of Guillain-Barré syndrome (GBS), a neurological autoimmune disorder caused by immune recognition of gangliosides and other components at nerve membranes. Using a high-throughput ELISA, we have analyzed the anti-glycolipid antibody profile, inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera-Correa, Juan, de Siqueira, Isadora Cristina, Mota, Sabrina, do Rosário, Mateus Santana, Pereira de Jesus, Pedro Antônio, Alcantara, Luiz Carlos Junior, Ernst, Joel D., Rodriguez, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764688/
https://www.ncbi.nlm.nih.gov/pubmed/31527907
http://dx.doi.org/10.1371/journal.pntd.0007695
_version_ 1783454428429287424
author Rivera-Correa, Juan
de Siqueira, Isadora Cristina
Mota, Sabrina
do Rosário, Mateus Santana
Pereira de Jesus, Pedro Antônio
Alcantara, Luiz Carlos Junior
Ernst, Joel D.
Rodriguez, Ana
author_facet Rivera-Correa, Juan
de Siqueira, Isadora Cristina
Mota, Sabrina
do Rosário, Mateus Santana
Pereira de Jesus, Pedro Antônio
Alcantara, Luiz Carlos Junior
Ernst, Joel D.
Rodriguez, Ana
author_sort Rivera-Correa, Juan
collection PubMed
description Zika virus infection is associated with the development of Guillain-Barré syndrome (GBS), a neurological autoimmune disorder caused by immune recognition of gangliosides and other components at nerve membranes. Using a high-throughput ELISA, we have analyzed the anti-glycolipid antibody profile, including gangliosides, of plasma samples from patients with Zika infections associated or not with GBS in Salvador, Brazil. We have observed that Zika patients that develop GBS present higher levels of anti-ganglioside antibodies when compared to Zika patients without GBS. We also observed that a broad repertoire of gangliosides was targeted by both IgM and IgG anti-self antibodies in these patients. Since Zika virus infects neurons, which contain membrane gangliosides, antigen presentation of these infected cells may trigger the observed autoimmune anti-ganglioside antibodies suggesting direct infection-induced autoantibodies as a cause leading to GBS development. Collectively, our results establish a link between anti-ganglioside antibodies and Zika-associated GBS in patients.
format Online
Article
Text
id pubmed-6764688
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-67646882019-10-11 Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil Rivera-Correa, Juan de Siqueira, Isadora Cristina Mota, Sabrina do Rosário, Mateus Santana Pereira de Jesus, Pedro Antônio Alcantara, Luiz Carlos Junior Ernst, Joel D. Rodriguez, Ana PLoS Negl Trop Dis Research Article Zika virus infection is associated with the development of Guillain-Barré syndrome (GBS), a neurological autoimmune disorder caused by immune recognition of gangliosides and other components at nerve membranes. Using a high-throughput ELISA, we have analyzed the anti-glycolipid antibody profile, including gangliosides, of plasma samples from patients with Zika infections associated or not with GBS in Salvador, Brazil. We have observed that Zika patients that develop GBS present higher levels of anti-ganglioside antibodies when compared to Zika patients without GBS. We also observed that a broad repertoire of gangliosides was targeted by both IgM and IgG anti-self antibodies in these patients. Since Zika virus infects neurons, which contain membrane gangliosides, antigen presentation of these infected cells may trigger the observed autoimmune anti-ganglioside antibodies suggesting direct infection-induced autoantibodies as a cause leading to GBS development. Collectively, our results establish a link between anti-ganglioside antibodies and Zika-associated GBS in patients. Public Library of Science 2019-09-17 /pmc/articles/PMC6764688/ /pubmed/31527907 http://dx.doi.org/10.1371/journal.pntd.0007695 Text en © 2019 Rivera-Correa et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rivera-Correa, Juan
de Siqueira, Isadora Cristina
Mota, Sabrina
do Rosário, Mateus Santana
Pereira de Jesus, Pedro Antônio
Alcantara, Luiz Carlos Junior
Ernst, Joel D.
Rodriguez, Ana
Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil
title Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil
title_full Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil
title_fullStr Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil
title_full_unstemmed Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil
title_short Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil
title_sort anti-ganglioside antibodies in patients with zika virus infection-associated guillain-barré syndrome in brazil
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764688/
https://www.ncbi.nlm.nih.gov/pubmed/31527907
http://dx.doi.org/10.1371/journal.pntd.0007695
work_keys_str_mv AT riveracorreajuan antigangliosideantibodiesinpatientswithzikavirusinfectionassociatedguillainbarresyndromeinbrazil
AT desiqueiraisadoracristina antigangliosideantibodiesinpatientswithzikavirusinfectionassociatedguillainbarresyndromeinbrazil
AT motasabrina antigangliosideantibodiesinpatientswithzikavirusinfectionassociatedguillainbarresyndromeinbrazil
AT dorosariomateussantana antigangliosideantibodiesinpatientswithzikavirusinfectionassociatedguillainbarresyndromeinbrazil
AT pereiradejesuspedroantonio antigangliosideantibodiesinpatientswithzikavirusinfectionassociatedguillainbarresyndromeinbrazil
AT alcantaraluizcarlosjunior antigangliosideantibodiesinpatientswithzikavirusinfectionassociatedguillainbarresyndromeinbrazil
AT ernstjoeld antigangliosideantibodiesinpatientswithzikavirusinfectionassociatedguillainbarresyndromeinbrazil
AT rodriguezana antigangliosideantibodiesinpatientswithzikavirusinfectionassociatedguillainbarresyndromeinbrazil